Citigroup Boosts Exelixis (NASDAQ:EXEL) Price Target to $45.00
Exelixis (NASDAQ:EXEL – Get Free Report) had its price target hoisted by investment analysts at Citigroup from $38.00 to $45.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Citigroup’s price objective suggests a potential upside of 30.47% from the […]
Exelixis (NASDAQ:EXEL – Get Free Report) had its price target hoisted by investment analysts at Citigroup from $38.00 to $45.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. Citigroup’s price objective suggests a potential upside of 30.47% from the […]
